Literature DB >> 513959

Pronounced inhibition of noradrenaline uptake by 10-hydroxymetabolites of nortriptyline.

L Bertilsson, B Mellström, F Sjöqvist.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 513959     DOI: 10.1016/0024-3205(79)90393-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  24 in total

Review 1.  The impact of the CYP2D6-polymorphism on dose recommendations for current antidepressants.

Authors:  Norbert Thuerauf; Jens Lunkenheimer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-08       Impact factor: 5.270

2.  Platelets and biogenic amines. 2. Indications for a discrete low affinity uptake mechanism shared by norepinephrine and 5-hydroxytryptamine in human platelets.

Authors:  R Malmgren
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  The effect of experimentally-induced renal failure on accumulation of bupropion and its major basic metabolites in plasma and brain of guinea pigs.

Authors:  C L DeVane; S C Laizure; D F Cameron
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Population pharmacokinetics and pharmacodynamics: potential use for gathering dose-concentration-response.

Authors:  M Jerling
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

5.  Serotonin uptake inhibition during treatment of depression with nortriptyline caused by parent drug and not by 10-hydroxymetabolites.

Authors:  R Malmgren; A Aberg-Wistedt; L Bertilsson
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

6.  The CYP2D6 polymorphism in relation to the metabolism of amitriptyline and nortriptyline in the Faroese population.

Authors:  Jónrit Halling; Pál Weihe; Kim Brosen
Journal:  Br J Clin Pharmacol       Date:  2007-08-31       Impact factor: 4.335

Review 7.  The Role of Metabolites of Antidepressants in the Treatment of Depression.

Authors:  M V Rudorfer; W Z Potter
Journal:  CNS Drugs       Date:  1997-04       Impact factor: 5.749

8.  The pharmacokinetics of nortriptyline in patients with chronic renal failure.

Authors:  S Dawlilng; K Lynn; R Rosser; R Braithwaite
Journal:  Br J Clin Pharmacol       Date:  1981-07       Impact factor: 4.335

9.  Biotransformation of amitriptyline in alcoholic depressive patients.

Authors:  M Sandoz; S Vandel; B Vandel; B Bonin; G Allers; R Volmat
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  The potential therapeutic role of the enantiomers and metabolites of mianserin.

Authors:  R M Pinder; A M Van Delft
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.